Showing results (31-40 of 51) with videos related to
Sort By:
Pageof 6
European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 6, 2004
Predictive value of impaired uterine transport function assessed by negative hysterosalpingoscintigraphy (HSSG)S Kissler, L Wildt, K Schmiedehausen, et al.Breast Cancer Research and Treatment|March 15, 2008
Gene expression of topoisomerase II alpha (TOP2A) by microarray analysis is highly prognostic in estrogen receptor (ER) positive breast cancerA Rody, T Karn, E Ruckhäberle, et al.Endocrine-Related Cancer|December 3, 2005
Methylation of estrogen receptor beta promoter correlates with loss of ER-beta expression in mammary carcinoma and is an early indication marker in premalignant lesionsA Rody, U Holtrich, C Solbach, et al.European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 3, 2007
Duration of dysmenorrhoea and extent of adenomyosis visualised by magnetic resonance imagingS Kissler, S Zangos, J Kohl, et al.Journal of Cancer Research and Clinical Oncology|March 8, 2023
Overexpression of the orphan nuclear receptor NR2F6 is associated with improved survival across molecular subgroups in endometrial cancer patientsL Proppe, T Jagomast, S Beume, et al.Zentralblatt Fur Gynakologie|May 5, 2006
Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signaturesA Rody, T Karn, R Gätje, et al.BJOG : an International Journal of Obstetrics and Gynaecology|September 20, 2005
Diminished pregnancy rates in endometriosis due to impaired uterotubal transport assessed by hysterosalpingoscintigraphyS Kissler, N Hamscho, S Zangos, et al.Archives of Gynecology and Obstetrics|January 23, 2025
Prognostic and clinical heterogeneity of PD1 and PD-L1- immunohistochemical scores in endometrial cancersL Proppe, T Jagomast, S Beume, et al.Archives of Gynecology and Obstetrics|January 9, 2021
A risk factor analysis of complications after surgery for vulvar cancerGeorgios Gitas, L Proppe, S Baum, et al.Breast (Edinburgh, Scotland)|April 24, 2007
The erbB2+ cluster of the intrinsic gene set predicts tumor response of breast cancer patients receiving neoadjuvant chemotherapy with docetaxel, doxorubicin and cyclophosphamide within the GEPARTRIO trialA Rody, T Karn, C Solbach, et al.Pageof 6